Dexilant approved to treat heartburn in younger patients

The Food and Drug Administration has approved Dexilant (dexlansoprazole) for gastroesophageal reflux disease patients aged 12-17 years, according to a press release from Takeda Pharmaceuticals. FDA...
Source: Pediatric News - Category: Journals (General) Source Type: news